Zydus Therapeutics Inc.
Clinical trials sponsored by Zydus Therapeutics Inc., explained in plain language.
-
New drug study aims to understand how liver disease affects medication
Knowledge-focused Recruiting nowThis early-stage study will test a drug called saroglitazar magnesium in 6 adults with moderate liver scarring (cirrhosis) caused by cholestatic liver disease. The main goal is to see how the drug moves through the body and if it is safe when taken every other day. Participants w…
Phase: PHASE1 • Sponsor: Zydus Therapeutics Inc. • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC
-
Liver drug study seeks to understand how body processes medication in scarred livers
Knowledge-focused Recruiting nowThis study looks at how the drug Saroglitazar is processed in people with mild, moderate, or severe liver scarring (cirrhosis) caused by cholestatic liver disease. About 30 adults will take the drug once daily for 28 days. The goal is to measure drug levels in the blood and check…
Phase: PHASE1 • Sponsor: Zydus Therapeutics Inc. • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:04 UTC